Open labelled evaluation of injection Manyana (a combination of diclofenac + pitofenone + fenpiverinium) in ureteric, biliary and intestinal spasm--a preliminary report.

To study the efficacy and safety of a parenteral formulation of 'Manyana' (a combination of diclofenac + pitofenone + fenpiverinium) in ureteric, biliary and intestinal colic, an open labelled study was conducted at two centres. A total of 206 patients were enrolled and evaluated for decrease in pain with time on a visual analogue scale. A statistically significant difference was observed in pain within 30 minutes of drug administration and the pain relief lasted for as long as 24 hours post dosing. The study shows definite synergism between the antispasmodics pitofenone and fenpiverinium with the NSAID-diclofenac, reducing the prostaglandin levels and also the spasm related to colic.
AuthorsK B Golhar, R L Gupta
JournalJournal of the Indian Medical Association (J Indian Med Assoc) Vol. 97 Issue 9 Pg. 398-400 (Sep 1999) ISSN: 0019-5847 [Print] INDIA
PMID10638099 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzophenones
  • Drug Combinations
  • Parasympatholytics
  • Piperidines
  • Diclofenac
  • fenpiverinium
  • pitofenone
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Benzophenones (therapeutic use)
  • Biliary Tract Diseases (drug therapy)
  • Colic (drug therapy)
  • Diclofenac (therapeutic use)
  • Drug Combinations
  • Female
  • Humans
  • Injections, Intramuscular
  • Intestinal Diseases (drug therapy)
  • Male
  • Middle Aged
  • Parasympatholytics (therapeutic use)
  • Piperidines (therapeutic use)
  • Ureteral Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: